Stay updated on Emricasan for Decompensated NASH Cirrhosis Clinical Trial
Sign up to get notified when there's something new on the Emricasan for Decompensated NASH Cirrhosis Clinical Trial page.

Latest updates to the Emricasan for Decompensated NASH Cirrhosis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe changes are administrative in nature: a new site revision tag (v3.4.2) and removal of an outdated funding notice, with no impact on the study details or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedDifference0.3%

- Check28 days agoChange DetectedShow glossary is now displayed, new labels 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' were added, and a revision note 'Revision: v3.4.0' was introduced. Deletions adjust wording to 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' and remove the older 'Revision: v3.3.4' label; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedA new Locations section was added, listing study sites by state (Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana, Iowa, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, New Jersey, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Virginia, Washington). The previous per-state location blocks were removed.SummaryDifference2%

- Check85 days agoChange DetectedRevision: v3.3.2; no substantive changes to study details, eligibility criteria, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check93 days agoChange DetectedPublication notes were updated to indicate PubMed entries are auto-filled and the revision tag updated to v3.3.1 (removing the older wording tied to v3.2.0).SummaryDifference0.1%

Stay in the know with updates to Emricasan for Decompensated NASH Cirrhosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Emricasan for Decompensated NASH Cirrhosis Clinical Trial page.